Cross Icon

Press Releases

Your source for Evernorth news.

Cross Icon
Featured

Evernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early next year

  • Estimated to save individual Accredo patients around $4,000 per year
  • Biosimilar price will be more than 80% lower than Stelara list price
  • Accredo patients benefit from the specialty pharmacy’s best-in-class clinical support
Read more
""

Filter Press Releases

Media contact:

media@evernorth.com
Press Release

Despite Stressors of Pandemic, 60 Percent of Women Say Their Plans to Have Children Have Not Changed, New Evernorth Report Finds

Three out of four women that stopped fertility treatments during the pandemic have either restarted or plan to within a year. Nearly 20 percent of older millennials and younger GenX women are accelera...

February 24, 21

Read More
Press Release

Evernorth Puts Affordable, Comprehensive Fertility Benefits In Reach for Millions of Americans With FamilyPath

October 21, 20

Read More
Press Release

Evernorth Continues Work to Reduce Costs and Improve Health With Expanded and Innovative Digital Health Formulary Platform

First-in-industry Digital Health Formulary is expanded to better enable people to find effective digital solutions that address their most pressing health care needs

October 07, 20

Read More